Printer Friendly Version
Amy Lange Miller is an intellectual property associate in the Chicago office of Locke Lord LLP. She focuses her practice on intellectual property disputes with an emphasis on patent litigation in the life sciences and pharmaceutical industries, including litigation involving the Hatch-Waxman provisions of the Patent Act. She also has experience in advising clients on drug launch risks and litigation strategy, as well as in conducting freedom to operate and likelihood of patent allowance analyses.
Previously, Amy was a registered nurse coordinating clinical trials of investigational drugs for US Food and Drug Administration approval in the areas of pain management biologics and viral
gene therapy. Prior to that, she worked in viral gene therapy research and co-authored several scientific articles on gene therapy and clotting factors. Amy relies on her experience in the drug research and development lifecycle in litigation, as well as in counselling clients in the life sciences and pharmaceutical industries.
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.